✦ LIBER ✦

UP-03.171 Efficacy and Safety of Onabotulinumtoxin A in Patients with Neurogenic Detrusor Overactivity: Pooled Analysis from Two Phase 3 Trials

✍ Scribed by Sievert, K.D.; Cruz, F.; Herschorn, S.; Gousse, A.; Heesakkers, J.; Keppenne, V.; Aliotta, P.; Thompson, C.; Lam, W.; Ginsberg, D.

Book ID: 123074894
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 75 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.07.1260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 3 efficacy and safety study of ona

Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

✍ Dmochowski, R.; Ginsberg, D.; Ethans, K.; Brin, M.; Lam, W.; Haag-Molkenteller, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

1515 PHASE 3 EFFICACY AND SAFETY STUDY O

1515 PHASE 3 EFFICACY AND SAFETY STUDY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

✍ Ginsberg, David; Gousse, Angelo; Keppenne, Véronique; Sievert, Karl-Dietrich; Th 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

694 Efficacy and safety of 2 administrat

694 Efficacy and safety of 2 administration modes of a single intra-detrusor injection of 750 units Dysport® (abobotulinum toxin-A) in patients suffering from neurogenic detrusor overactivity (NDO): A Phase IIa study

✍ Denys, P.; Del Popolo, G.; Amarenco, G.; Karsenty, G.; Radziszewski, P.; Perroui 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Efficacy and safety of efalizumab in a l

Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials

✍ Kenneth Gordon; David Pariser; Richard Langley; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efficacy and safety of darunavir-ritonav

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

✍ Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 180 KB

Efficacy and safety of fenofibric acid i

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

✍ Peter H. Jones; Michael H. Davidson; Anne C. Goldberg; Carl J. Pepine; Maureen T 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 419 KB